HALO Short Interest Reverses as Analyst Targets Jump Ahead of November Print
Halozyme Therapeutics enters the final stretch before its November 3 earnings with a notable reversal in the short-selling picture: after weeks of shorts quietly retreating, the position has rebuilt sharply this week,…